Search

Your search keyword '"Tanaka, Nobuyuki"' showing total 153 results

Search Constraints

Start Over You searched for: Author "Tanaka, Nobuyuki" Remove constraint Author: "Tanaka, Nobuyuki" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
153 results on '"Tanaka, Nobuyuki"'

Search Results

1. Appropriate definition of non-metastatic castration-resistant prostate cancer (nmCRPC) and optimal timing of androgen receptor signaling inhibitor (ARSI)

2. Genomic profiling and clinical utility of circulating tumor DNA in metastatic prostate cancer: SCRUM-Japan MONSTAR SCREEN project

3. Prediction of pathological up-staging after radical nephroureterectomy in patients with upper tract urothelial carcinoma

5. Loss of p53 function promotes DNA damage-induced formation of nuclear actin filaments

10. Prognostic role of the innate immune signature CD163 and “eat me” signal calreticulin in clear cell renal cell carcinoma

11. IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation

13. Hybridisation chain reaction-based visualisation and screening for lncRNA profiles in clear-cell renal-cell carcinoma

17. Human iPS cell derived RPE strips for secure delivery of graft cells at a target place with minimal surgical invasion

18. Landscape of prognostic signatures and immunogenomics of the AXL/GAS6 axis in renal cell carcinoma

20. Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy

21. Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma

22. On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma

28. Long-term follow-up comparing salvage radiation therapy and androgen-deprivation therapy for biochemical recurrence after radical prostatectomy

31. Can random bladder biopsies be eliminated after bacillus Calmette–Guérin therapy against carcinoma in situ?

33. Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching

34. Three-dimensional single-cell imaging for the analysis of RNA and protein expression in intact tumour biopsies

36. Cochlear supporting cells function as macrophage-like cells and protect audiosensory receptor hair cells from pathogens

40. Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy

41. First molecular phylogenetic insights into the evolution of Eriocaulon (Eriocaulaceae, Poales)

42. Modeling future wildlife habitat suitability: serious climate change impacts on the potential distribution of the Rock Ptarmigan Lagopus muta japonica in Japan’s northern Alps

44. Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients

Catalog

Books, media, physical & digital resources